Publicaciones en colaboración con investigadores/as de Karolinska University Hospital (21)

2021

  1. Clonogenic Assays to Detect Cell Fate in Mitotic Catastrophe

    Methods in Molecular Biology (Humana Press Inc.), pp. 227-239

  2. Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtype

    Cell Death and Disease, Vol. 12, Núm. 11

2020

  1. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

    Nature Communications, Vol. 11, Núm. 1

  2. Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (Nature Communications, (2020), 11, 1, (3819), 10.1038/s41467-020-17644-0)

    Nature Communications

2019

  1. Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer (Nature Communications, (2019), 10, 1, (1486), 10.1038/s41467-019-09415-3)

    Nature Communications

  2. Crizotinib-induced immunogenic cell death in non-small cell lung cancer

    Nature Communications, Vol. 10, Núm. 1

  3. Suppression of tumor antigen presentation during aneuploid tumor evolution contributes to immune evasion

    OncoImmunology, Vol. 8, Núm. 11

2018

  1. Calcium signaling and cell cycle: Progression or death

    Cell Calcium, Vol. 70, pp. 3-15

  2. Immune effectors responsible for the elimination of hyperploid cancer cells

    OncoImmunology, Vol. 7, Núm. 8

  3. eIF2α phosphorylation is pathognomonic for immunogenic cell death

    Cell Death and Differentiation, Vol. 25, Núm. 8, pp. 1375-1393

2017

  1. Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance

    Immunological Reviews, Vol. 280, Núm. 1, pp. 165-174

2016

  1. Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate

    OncoImmunology, Vol. 5, Núm. 6

  2. Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

    Cancer Cell, Vol. 30, Núm. 1, pp. 147-160

  3. Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer

    OncoImmunology, Vol. 5, Núm. 6

  4. Positive impact of autophagy in human breast cancer cells on local immunosurveillance

    OncoImmunology, Vol. 5, Núm. 6

  5. The oncolytic peptide LTX-315 triggers immunogenic cell death

    Cell Death and Disease, Vol. 7, Núm. 3

  6. The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer

    Autophagy, Vol. 12, Núm. 5, pp. 864-875

  7. The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ

    OncoImmunology, Vol. 5, Núm. 10

2015

  1. Karyotypic Aberrations in Oncogenesis and Cancer Therapy

    Trends in Cancer, Vol. 1, Núm. 2, pp. 124-135

  2. Morphometric analysis of immunoselection against hyperploid cancer cells

    Oncotarget, Vol. 6, Núm. 38, pp. 41204-41215